cephalexin has been researched along with ly 163892 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 7 (41.18) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clauss, W; Daniel, H; Gebert, I; Weber, WM; Weintraut, H; Wenzel, U | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Indelicato, JM; Pasini, CE | 1 |
| Brier, G; Kovach, PM; Lantz, RJ | 1 |
| Hirata, T; Matsukuma, I; Mochida, K; Okachi, R; Sato, K | 1 |
| Fontana, R; Pelosi, E | 1 |
| Barry, AL; Jones, RN | 2 |
| Knapp, CC; Washington, JA | 1 |
| Daniel, H; Thwaites, DT; Wenzel, U | 1 |
| Chen, J; Dantzig, AH; Hu, M; Stratford, RE; Zheng, L | 1 |
| Berry, DM; Dantzig, AH; Duckworth, DC; Snyder, NJ; Spry, DO; Tabas, LB | 1 |
1 review(s) available for cephalexin and ly 163892
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for cephalexin and ly 163892
| Article | Year |
|---|---|
Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
Topics: Animals; Biological Transport; Caco-2 Cells; Carrier Proteins; Cephalosporins; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Oocytes; Peptide Transporter 1; Rabbits; Symporters; Xenopus laevis | 1996 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.
Topics: Cefaclor; Cephalexin; Cephalosporins; Chromatography, High Pressure Liquid; Colorimetry; Crystallization; Drug Stability; Hydrogen-Ion Concentration; Isoelectric Focusing; Kinetics; Solubility; Solutions; Thermodynamics; X-Ray Diffraction | 1992 |
High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine.
Topics: Cefaclor; Cephalexin; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Molecular Structure; Spectrophotometry, Ultraviolet | 1991 |
In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.
Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cephalexin; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests | 1989 |
In vitro activity and beta-lactamase stability of LY163892.
Topics: Administration, Oral; Bacteria; beta-Lactamases; Cefaclor; Cefotaxime; Cephalexin; Cephalosporins; Enzyme Stability | 1988 |
Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
Topics: Bacteria; Cefaclor; Cephalexin; Cephalosporins; Microbial Sensitivity Tests | 1988 |
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
Topics: Bacteria; Cefaclor; Cephalexin; Cephalosporins; Enterobacter; Haemophilus influenzae; Microbial Sensitivity Tests; Predictive Value of Tests; Providencia | 1988 |
In vitro activities of LY163892, cefaclor, and cefuroxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Drug Stability; Temperature | 1988 |
FDA announces recall of liquid antibiotics.
Topics: Cefaclor; Cephalexin; Cephalosporins; Drug and Narcotic Control; United States; United States Food and Drug Administration | 1994 |
Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter.
Topics: Animals; Anti-Bacterial Agents; Cadherins; Carrier Proteins; Cell Line; Cephalexin; Cephalosporins; Hydrolysis; Intestinal Mucosa; Membrane Transport Proteins; Microinjections; Oocytes; Peptides; Stereoisomerism; Xenopus laevis | 1995 |
Uptake characteristics of loracarbef and cephalexin in the Caco-2 cell culture model: effects of the proton gradient and possible presence of a distinctive second component.
Topics: Caco-2 Cells; Cephalexin; Cephalosporins; Humans; Peptides; Protons | 1996 |
Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells.
Topics: Caco-2 Cells; Cadherins; Carrier Proteins; Cephalexin; Cephalosporins; Humans; Lactams; Membrane Transport Proteins; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship | 1997 |